Insomnia symptoms in adulthood. Prevalence and incidence over 25 years.

Autor: Klimt F; Technische Universität Dresden, Carl Gustav Carus Faculty of Medicine, Division of Psychological and Social Medicine and Developmental Neurosciences, Research Group Applied Medical Psychology and Medical Sociology, Fetscherstr. 74, 01307, Dresden, Germany. Electronic address: Franziska.Klimt@gmx.de., Jacobi C; Technische Universität Dresden, School of Humanities and Social Sciences, Disruption and Societal Change Center TUDiSC, 01217, Dresden, Germany. Electronic address: ClaraCarlotta.Jacobi@ukdd.de., Brähler E; University Medical Center Mainz, Department of Psychosomatic Medicine and Psychotherapy, 55131, Mainz, Germany; Universitätsklinikum Leipzig, Klinik und Poliklinik für Psychiatrie und Psychotherapie, 04103, Leipzig, Germany. Electronic address: ebraehle@uni-mainz.de., Stöbel-Richter Y; University of Applied Science Zittau/Görlitz, Faculty of Management and Cultural Studies, 02826, Görlitz, Germany. Electronic address: yve.Stoebel-Richter@hszg.de., Zenger M; University of Applied Sciences Magdeburg-Stendal, 39576, Stendal, Germany; Integrated Research and Treatment Center AdiposityDiseases - Behavioral Medicine, Psychosomatic Medicine and Psychotherapy, University of Leipzig Medical Center, 04103, Leipzig, Germany. Electronic address: markus.zenger@h2.de., Berth H; Technische Universität Dresden, Carl Gustav Carus Faculty of Medicine, Division of Psychological and Social Medicine and Developmental Neurosciences, Research Group Applied Medical Psychology and Medical Sociology, Fetscherstr. 74, 01307, Dresden, Germany. Electronic address: h.berth@ukdd.de.
Jazyk: angličtina
Zdroj: Sleep medicine [Sleep Med] 2023 Sep; Vol. 109, pp. 240-244. Date of Electronic Publication: 2023 Jul 16.
DOI: 10.1016/j.sleep.2023.07.013
Abstrakt: Objective/background: Despite its high prevalence, little information is available about the course of insomnia symptoms over the life span. In this study, we analyzed the self-reported insomnia symptoms of the general population over more than 20 years, covering young up to middle adulthood.
Patients/methods: Data from waves 12 to 32 of the Saxon Longitudinal Study (1996-2021), were analyzed. Based on data from the 12th wave, n = 115 adults (48 men (41.7%), 67 women (58.3%), M age  = 23.59, SD = 0.59) completed the G-Score Item #3 in the following 18 waves, thus forming the basis for our analyses. The G-Score Item #3 reads "In the last 12 months, have you had the following complaints? Please indicate how often they occurred - Insomnia". The G-Score Item #3 was dichotomized using a cut-off score of 2, and prevalence and incidence rates were calculated by gender.
Results: The minimum prevalence rate was 23.48% (M age  = 32.11, SD = 0.40), and the maximum was 47.83% (M age  = 48.43, SD = 0.64), indicating an increase in insomnia symptoms with age. In most cases, no evidence was found for gender differences in prevalence rates. The incidence rates were 10.43% for the 1st year of follow-up and 8.7% for the 5th year and 6th year of follow-up, respectively.
Conclusions: This study provides further evidence for the high prevalence rates of insomnia symptoms in the general population. As this study is the first epidemiological study of insomnia symptoms based on a single-item (screening) instrument, it should be rather seen as an extension than a replication of previous study findings.
Competing Interests: Declaration of competing interest Franziska Klimt, Clara Jacobi, Elmar Brähler, Yve Stöbel-Richter, Markus Zenger and Hendrik Berth declare no conflict of interest.
(Copyright © 2023 Elsevier B.V. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: